Sanofi wins 1st US babies-to-adults 4-strain flu vax
This article was originally published in Scrip
Executive Summary
With the FDA's nod to Sanofi Pasteur's Fluzone Quadrivalent vaccine, Americans now have three four-strain flu vaccine options, with the company following last year's US approval of MedImmune's FluMist Quadrivalent, a live-attenuated nasal vaccine, and GlaxoSmithKline's Fluarix Quadrivalent, an intramuscular shot (scripintelligence, 1 March 2012, 17 December 2012).